Taipei, Taiwan

Shuenn-Chen Yang



Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovations and Contributions of Shuenn-Chen Yang

Introduction

Shuenn-Chen Yang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 3 patents, Yang's work focuses on developing targeted therapies for cancer treatment.

Latest Patents

One of his latest patents is titled "Dnazyme for silencing the expression of EGFR." This invention provides DNAzymes capable of silencing the expression of EGFR at an allele-specific level. These allele-specific DNAzymes target the EGFR T790M mutation, effectively knocking down the expression of EGFR T790M mRNA while preserving the wild-type mRNA. This innovation may help overcome T790M-derived TKI resistance, resulting in fewer unwanted side effects on normal cells in lung cancer patients. Another significant patent is for "Antofine and cryptopleurine derivatives as anticancer agents." This invention includes compounds of specific formulas and methods for their use in cancer treatment.

Career Highlights

Shuenn-Chen Yang has worked with prestigious institutions such as National Taiwan University and Academia Sinica. His research has been pivotal in advancing cancer therapies and improving patient outcomes.

Collaborations

Yang has collaborated with esteemed colleagues, including Pan-Chyr Yang and Konan Peck, to further his research and innovations in the field.

Conclusion

Shuenn-Chen Yang's contributions to cancer research through his patents and collaborations highlight his commitment to improving treatment options for patients. His innovative work continues to inspire advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…